title: Palbociclib: an approval at last for HER2-negative breast cancer.
authors.affiliation: Centre for Biosystems & Genomic Network Medicine, University of Ioannina, Ioannina, Greece.|Department of Surgery, Ioannina University Hospital, Ioannina, Greece.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Zerdes
authors.affiliation: Centre for Biosystems & Genomic Network Medicine, University of Ioannina, Ioannina, Greece.|Department of Surgery, 'G Hatzikosta' General Hospital, Ioannina, Greece.
authors.forename: Demosthenes E
authors.initials: DE
authors.lastname: Ziogas
authors.affiliation: Department of Plastic Surgery, Ioannina University School of Medicine, Ioannina, Greece.
authors.forename: Efstathios G
authors.initials: EG
authors.lastname: Lykoudis
authors.affiliation: Centre for Biosystems & Genomic Network Medicine, University of Ioannina, Ioannina, Greece.|Department of Surgery, Ioannina University Hospital, Ioannina, Greece.|Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.
authors.forename: Dimitrios H
authors.initials: DH
authors.lastname: Roukos
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D005260:Female; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D010879:Piperazines; D011725:Pyridines; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human; C500026:palbociclib
keywords: HER2-negative; breast cancer; metastasis; palbociclib